News & Updates
WellDoc, developers of the first FDA cleared mobile prescription therapy, BlueStar, closed funding from its first institutional investors, Merck Global Health Innovation Fund and Windham Venture Partners, as part of a $20 million round of financing.
EarlySense received FDA Clearance for the EarlySense 2.0 System, a newly designed bedside monitor for continuous measurement of respiration rate, heart rate and motion, in an automatic and contact-free manner.
Aetna Better Health and Addus Home Care will conduct a pilot study on the impact of providing smart phones to home care aides. Aides will use the phones to report changing health conditions in real time to supervisors and primary care physicians.
Seattle based biotech startup ActX raised $1.9M in seed fund. The oversubscribed round was led by Alliance of Angels. ActX aims to provide actionable genomic information to clinics and medical practices.
Millennium Laboratories, a medication monitoring and pharmacogenetic testing company, acquired RxAnte, a health care predictive analytics company, in order to add population drug therapy management and predictive capabilities for optimizing medication outcomes.
India based startup Commerzpoint Networks raised $400K in seed funding from Unitus Seed Fund. Commerzpoints owns Medypal, an online health care marketplace where medical consumers get quotes for medical procedures from providers who “bid” for their business.
Kolibree Smart Toothbrush is an electric toothbrush that connects to a user’s smartphone via Bluetooth and transmits data about frequency, brushing time, and brushing zones. The app displays progress with a score, gives badges to reward improvement, and allows to add up to 5 users.
According to a new study, web and telehealth based cognitive behavioral therapy shows significant promise in helping patients with chronic insomnia. More than half of the patients in this study reported improved productivity after receiving CBT through one of these methods.